“Randomized open controlled clinical study of therapeutic effect of Ekvisantiko guggulu orally and Vidravan Tailam topically with comparison to PanchatiktaGhrita Guggulu orally and Karanjadi Tailam topically in Vicharchika patients with special reference Array Section Original Research Articles
##plugins.themes.academic_pro.article.main##
Abstract
Introduction - All kushtha are having Tridosha origin so vicharchika can be said in Same way that is Kapha is responsible for kandu (itching), Pitta is responsible For Strav (discharge) and Vata is responsible for shyava Varna (blackish Discoloration) through the features of Vicharchika denotes its tridoshatmak Nature, it is mainly a Kapha dominant vyadhi.
Al the clinical features of Vicharchika can be very well correlated to Clinical features of Eczema.
Aim and objectives – To study the therapeutic effect of Ekvisantiko Guggulu and Vidravan tailam with Panchatiktaghrita Guggulu and Karanjadi tailam in the management of Vicharchika.
Material and methods – Total 60 patients of Vicharchika selected randomly which is then divided into two equal Groups i.e. 30 patients in each group. Giving intervention by Ekvisantiko Guggulu orally and Vidravan Tailam topically for group A and Panchatiktaghrita Guggulu orally and Karanjadi Tailam topically for group B for 30 days treatment and follow up taken for post therapy 45 days. Analysis of all patients were done and after that Result and conclusion were drawn.
Result and Conclusion – Ekvisantiko Guggulu and Vidravan Tailam with Panchatiktaghrita Guggulu and Karajadi tailam both are effective in the management of Vicharchika to reduce the sign and symptoms i.e. Kandu, Shyava Varna, Rukshata, Pidika, strav, Rajyo, Ruja, Lohit Varna. On the basis of overall percent relief, Ekvisantiko Guggulu orally and Vidravan tailam topically has found more effective than that of Panchatiktaghrita Guggulu orally and Karanjadi Tailam topically in the management of Vicharchika.
##plugins.themes.academic_pro.article.details##

This work is licensed under a Creative Commons Attribution 4.0 International License.